BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12200999)

  • 1. [Thyroid papillary microcarcinoma. Salah Azaiz Institute experience].
    Oueslati Z; Aloui M; Gritli S; Touati S; el-May A; Gamoudi A; Ben-Slimene F; Ladgham A
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(1):39-42. PubMed ID: 12200999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
    Cheema Y; Olson S; Elson D; Chen H
    J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our experience with papillary microcarcinoma of the thyroid].
    Garrel R; Cartier C; Marvaso V; Corpelet D; Makeieff M; Crampette L; Guerrier B
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(4):239-42. PubMed ID: 12723489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
    Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
    Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of radioactive iodine therapy in young patients with papillary thyroid cancer.
    Kuo SF; Chao TC; Chang HY; Hsueh C; Chang YC; Yang CH; Lin JD
    Clin Nucl Med; 2009 Jan; 34(1):4-6. PubMed ID: 19092372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of radiotherapy in the treatment of carcinoma of the thyroid gland].
    Mancini M; Malinverni G; Giordana C
    Minerva Med; 1988 Oct; 79(10):873-81. PubMed ID: 2460800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary microcarcinoma of the thyroid.
    Shaha AR; Tuttle RM; Shah JP
    J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
    [No Abstract]   [Full Text] [Related]  

  • 13. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts.
    Hartl DM; Al Ghuzlan A; Chami L; Leboulleux S; Schlumberger M; Travagli JP
    Ann Surg Oncol; 2009 Sep; 16(9):2595-601. PubMed ID: 19565286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas ligand (FasL, Apo-1L/CD95L) expression and clinical outcome in papillary microcarcinoma and papillary thyroid carcinomas with diameter smaller than 1.5 centimeters.
    Bayraktaroglu T; Boztepe H; Kapran Y; Tanakol R; Alagöl F
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):537-43. PubMed ID: 20013612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Papillary thyroid microcarcinoma revealed by cervical adenopathy].
    Abboud B; Sebaaly G
    J Med Liban; 2003; 51(3):138-42. PubMed ID: 15707074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary thyroid microcarcinoma: a surgical perspective.
    Sakorafas GH; Giotakis J; Stafyla V
    Cancer Treat Rev; 2005 Oct; 31(6):423-38. PubMed ID: 16005155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
    Lin JD; Chao TC; Hsueh C
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.